Joon Kim Selected Research

ribosomal protein S3

1/2021	Production, characterization, and epitope mapping of monoclonal antibodies of ribosomal protein S3 (rpS3).
12/2016	Ribosomal protein S3 (rpS3) secreted from various cancer cells is N-linked glycosylated.
11/2015	Dissociation of MIF-rpS3 complex and sequential NF-κB activation is involved in IR-induced metastatic conversion of NSCLC.
11/2013	Ribosomal protein S3 is secreted as a homodimer in cancer cells.
2/2013	Phosphorylation of ribosomal protein S3 and antiapoptotic TRAF2 protein mediates radioresistance in non-small cell lung cancer cells.
10/2010	Transduced PEP-1-ribosomal protein S3 (rpS3) ameliorates 12-O-tetradecanoylphorbol-13-acetate-induced inflammation in mice.
6/2008	Ischemia-induced ribosomal protein S3 expressional changes and the neuroprotective effect against experimental cerebral ischemic damage.
8/2006	Reduction of invasion in human fibrosarcoma cells by ribosomal protein S3 in conjunction with Nm23-H1 and ERK.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Joon Kim Research Topics

Disease

43	Neoplasms (Cancer) 04/2022 - 12/2003
8	Inflammation (Inflammations) 04/2022 - 10/2010
8	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2021 - 02/2013
7	Breast Neoplasms (Breast Cancer) 01/2022 - 07/2007
5	Neoplasm Metastasis (Metastasis) 11/2019 - 08/2006
5	Lung Neoplasms (Lung Cancer) 09/2019 - 07/2007
4	Melanoma (Melanoma, Malignant) 01/2022 - 03/2016
4	Colorectal Neoplasms (Colorectal Cancer) 12/2021 - 10/2016
4	Ciliopathies 10/2019 - 06/2014
4	Starvation 12/2018 - 06/2007
3	Carcinogenesis 01/2020 - 11/2008
3	Hepatocellular Carcinoma (Hepatoma) 10/2016 - 07/2003
3	Rheumatoid Arthritis 07/2005 - 07/2002
2	Fibrosis (Cirrhosis) 04/2022 - 01/2021
2	Wounds and Injuries (Trauma) 04/2022 - 05/2020
2	Pain (Aches) 01/2022 - 04/2015
2	Infections 08/2021 - 11/2003
2	Adenocarcinoma of Lung 01/2021 - 09/2017
2	Cardiomyopathies (Cardiomyopathy) 01/2021 - 12/2007
2	Osteosarcoma (Osteogenic Sarcoma) 05/2020 - 11/2019
2	Carcinoma (Carcinomatosis) 01/2019 - 01/2019
2	Liver Neoplasms (Liver Cancer) 03/2017 - 11/2016
2	Hypoxia (Hypoxemia) 06/2016 - 07/2015
2	Aneuploidy (Aneuploid) 09/2015 - 12/2009
2	Parkinson Disease (Parkinson's Disease) 09/2015 - 02/2013
2	Fibrosarcoma 11/2013 - 08/2006
2	Ischemia 12/2011 - 06/2008
2	Edema (Dropsy) 05/2011 - 10/2010
2	Seizures (Absence Seizure) 03/2008 - 08/2007
2	Mumps 05/2004 - 11/2003
1	Fecal Incontinence 01/2022
1	Type 2 Diabetes Mellitus (MODY) 01/2022
1	AIDS-Related Complex (ARC) 10/2021
1	Systemic candidiasis 08/2021
1	Mycoses (Diseases, Fungus) 08/2021
1	Adenomatous Polyposis Coli (Familial Adenomatous Polyposis) 07/2021
1	Cardiotoxicity 01/2021
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2021
1	Alzheimer Disease (Alzheimer's Disease) 01/2021
1	Pulmonary Fibrosis (Fibrosing Alveolitis) 01/2021
1	Stomach Neoplasms (Stomach Cancer) 01/2021

Drug/Important Bio-Agent (IBA)

27	Proteins (Proteins, Gene)FDA Link 01/2021 - 11/2004
8	ribosomal protein S3IBA 01/2021 - 08/2006
5	Pharmaceutical PreparationsIBA 04/2022 - 10/2016
5	MicroRNAs (MicroRNA)IBA 08/2019 - 09/2013
5	CytokinesIBA 01/2019 - 10/2010
5	EnzymesIBA 12/2011 - 05/2004
4	Reactive Oxygen Species (Oxygen Radicals)IBA 12/2021 - 06/2014
3	CollagenIBA 01/2022 - 03/2017
3	CateninsIBA 07/2021 - 01/2016
3	Phosphotransferases (Kinase)IBA 01/2020 - 11/2008
3	DNA (Deoxyribonucleic Acid)IBA 01/2020 - 11/2004
3	Interleukin-6 (Interleukin 6)IBA 01/2019 - 05/2011
3	Messenger RNA (mRNA)IBA 01/2019 - 07/2003
3	Small Interfering RNA (siRNA)IBA 01/2019 - 05/2015
3	Amino Acids FDA Link 12/2018 - 06/2007
3	NM23 Nucleoside Diphosphate KinasesIBA 09/2009 - 08/2006
2	Mercaptoethanol (2 Mercaptoethanol)IBA 04/2022 - 01/2021
2	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 01/2021
2	LipidsIBA 01/2021 - 01/2018
2	Zoledronic Acid (Zometa)FDA Link 05/2020 - 11/2019
2	Tyrosine Kinase InhibitorsIBA 09/2019 - 09/2017
2	InterleukinsIBA 01/2019 - 10/2013
2	ErbB Receptors (EGF Receptor)IBA 01/2019 - 09/2017
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2019 - 05/2011
2	RNA (Ribonucleic Acid)IBA 01/2018 - 12/2014
2	VemurafenibIBA 01/2018 - 03/2016
2	ArrestinIBA 01/2017 - 01/2016
2	Sirtuin 1IBA 09/2015 - 07/2015
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 07/2015 - 01/2014
2	Biomarkers (Surrogate Marker)IBA 12/2014 - 03/2010
2	NF-kappa B (NF-kB)IBA 12/2011 - 10/2010
2	ProteomeIBA 03/2010 - 03/2008
2	4-Butyrolactone (gamma Butyrolactone)IBA 03/2008 - 08/2007
2	Viral ProteinsIBA 07/2006 - 12/2003
2	Chemokine ReceptorsIBA 02/2003 - 07/2002
2	ChemokinesIBA 02/2003 - 07/2002
1	Hypoxia-Inducible Factor 1IBA 04/2022
1	2-MethoxyestradiolIBA 04/2022
1	Focal Adhesion Protein-Tyrosine KinasesIBA 01/2022
1	Transcription Factors (Transcription Factor)IBA 01/2022
1	Fibronectins (Fibronectin)IBA 01/2022
1	JNK Mitogen-Activated Protein KinasesIBA 01/2022
1	Insulin (Novolin)FDA Link 01/2022
1	Podophyllotoxin (Condylox)FDA LinkGeneric 12/2021
1	Antifungal AgentsIBA 08/2021
1	Protein Isoforms (Isoforms)IBA 01/2021
1	Apolipoproteins E (ApoE)IBA 01/2021
1	ApolipoproteinsIBA 01/2021
1	Neural Cell Adhesion Molecule L1 (L1 Cell Adhesion Molecule)IBA 01/2021
1	EndonucleasesIBA 01/2021
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2021
1	tdTomatoIBA 01/2021
1	hydroxide ionIBA 05/2020

Therapy/Procedure

12	Radiotherapy 04/2022 - 05/2013
12	Therapeutics 10/2021 - 12/2006
3	Drug Therapy (Chemotherapy) 11/2019 - 01/2017
1	Enema (Enemas) 01/2022
1	Image-Guided Radiotherapy 01/2021
1	Cautery 05/2020